Revalation







Here is an article describing the issue:

http://www.businessweek.com/news/20...rugs-get-scrutiny-on-possible-cancer-tie.html

THis is a key passage from the article:

"Regulators already have taken note of possible links between the new classes of diabetes drugs and pancreatitis and thyroid tumors. Still, the renewed debate may prompt authorities to seek additional safety data before approving new GLP-1 drugs, Ele Ferrannini of the University of Pisa School of Medicine said in a telephone interview."

Therefore, it could make approval of Lilly's GLP-1-Fc fusion more challenging.